Gottlieb Vibeke, Lyngsø Anne Marie, Sæbye Ditte, Frølich Anne, Backer Vibeke
Respiratory Research Unit, Department of Respiratory Medicine, Bispebjerg University Hospital, Copenhagen, Denmark.
Research Unit for Chronic Conditions, Bispebjerg and Frederiksberg University Hospital, Copenhagen, Denmark.
Eur Clin Respir J. 2016 Jun 22;3. doi: 10.3402/ecrj.v3.30232. eCollection 2016.
Several studies have shown that the use of pulmonary medication is widespread and often initiated without initial spirometry. Early detection of chronic obstructive pulmonary disease (COPD) by spirometry in General Practice is essential for an early and correct implementation of medical treatment.
The aim of the present study was to evaluate the use of regular therapy following diagnostic spirometry for COPD in General Practice from February 2008 to February 2009.
Spirometry data and results were linked through Statistics Denmark with information from the Register of Medicinal Product Statistics using the unique personal identification code. Data were analysed to evaluate the impact of screening on use of regular COPD therapy. Primary outcome was initiation of regular therapy following COPD diagnosis with spirometry.
In a population of 3,376 individuals at risk, 1,458 underwent spirometric assessment with 631 being diagnosed with COPD; 110 of those received regular therapy before assessment with this figure increasing to 161 after spirometry. Of 827 participants not receiving a COPD diagnosis, 36 received regular therapy prior to assessment and 42 received regular therapy after spirometry despite no established COPD diagnosis.
There is a significant chance of receiving regular therapy after being diagnosed with COPD. However, a large proportion of subjects diagnosed with COPD did not receive regular therapy following diagnosis. Efforts should be made to ensure correct diagnosis and correct medical treatment according to guidelines in individuals with COPD.
多项研究表明,肺部药物的使用很普遍,而且常常在未进行初始肺活量测定的情况下就开始使用。在全科医疗中通过肺活量测定早期发现慢性阻塞性肺疾病(COPD)对于早期正确实施药物治疗至关重要。
本研究的目的是评估2008年2月至2009年2月在全科医疗中对COPD进行诊断性肺活量测定后常规治疗的使用情况。
通过丹麦统计局,利用唯一的个人识别码将肺活量测定数据和结果与药品统计登记册中的信息相联系。对数据进行分析以评估筛查对COPD常规治疗使用的影响。主要结局是在通过肺活量测定诊断COPD后开始常规治疗。
在3376名有风险的个体中,1458人接受了肺活量测定评估,其中631人被诊断为COPD;这些人中110人在评估前接受了常规治疗,这一数字在肺活量测定后增至161人。在827名未被诊断为COPD的参与者中,36人在评估前接受了常规治疗,42人在肺活量测定后接受了常规治疗,尽管未确诊为COPD。
被诊断为COPD后接受常规治疗的可能性很大。然而,很大一部分被诊断为COPD的患者在诊断后未接受常规治疗。应努力确保对COPD患者按照指南进行正确诊断和正确治疗。